» Articles » PMID: 15743669

Dopaminergic Neurons

Overview
Publisher Elsevier
Date 2005 Mar 4
PMID 15743669
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

Dopaminergic neurons of the midbrain are the main source of dopamine (DA) in the mammalian central nervous system. Their loss is associated with one of the most prominent human neurological disorders, Parkinson's disease (PD). Dopaminergic neurons are found in a 'harsh' region of the brain, the substantia nigra pars compacta, which is DA-rich and contains both redox available neuromelanin and a high iron content. Although their numbers are few, these dopaminergic neurons play an important role in the control of multiple brain functions including voluntary movement and a broad array of behavioral processes such as mood, reward, addiction, and stress. Studies into the developmental pathways which are involved in the generation of dopaminergic neurons in the brain have led to the identification of several specific transcription factors including Nurr1, Lmx1b and Pitx3, all shown to be important in the development of the mesencephalic dopaminergic system. The selective degeneration of these dopaminergic neurons in the substantia nigra pars compacta leads to PD but the exact cause for this nigral cell loss is still unknown.

Citing Articles

Epigallocatechin-3-Gallate, Quercetin, and Kaempferol for Treatment of Parkinson's Disease Through Prevention of Gut Dysbiosis and Attenuation of Multiple Molecular Mechanisms of Pathogenesis.

Kalu A, Ray S Brain Sci. 2025; 15(2).

PMID: 40002477 PMC: 11853474. DOI: 10.3390/brainsci15020144.


A novel approach to metabolic profiling in case models of MECP2-related disorders.

Cooley Coleman J, Moffitt B, Bridges W, Jones K, May M, Skinner C Metab Brain Dis. 2025; 40(2):124.

PMID: 39945871 PMC: 11825590. DOI: 10.1007/s11011-025-01546-5.


Focused Ultrasound Modulates Dopamine in a Mesolimbic Reward Circuit.

Olaitan G, Ganesana M, Strohman A, Lynch W, Legon W, Venton B J Neurochem. 2025; 169(2):e70001.

PMID: 39902479 PMC: 11791541. DOI: 10.1111/jnc.70001.


Asymmetric Synthesis of 2-Arylethylamines: A Metal-Free Review of the New Millennium.

Manchado A, Garcia-Gonzalez A, Nieto C, Diez D, Garrido N Molecules. 2024; 29(23).

PMID: 39683888 PMC: 11643920. DOI: 10.3390/molecules29235729.


Hsa_Circ_0105596/FTO inhibits progression of Parkinson's disease by sponging miR-187-3p and regulating eEF2.

Feng J, Zhao J, Kuang Y, Zhou Y, Ye Z, He Y Heliyon. 2024; 10(23):e39830.

PMID: 39654770 PMC: 11626004. DOI: 10.1016/j.heliyon.2024.e39830.